Fort Cady Borate Project DFS progressing well

By Trevor Hoey. Published at Sep 25, 2018, in Mining

American Pacific Borate and Lithium Ltd (ASX:ABR) has provided an update on its progress as it seeks to complete the definitive feasibility study (DFS) for its Fort Cady Borate Project in the December quarter of 2018.

As a backdrop, the Fort Cady project is in Southern California, and the resource is a highly rare and large colemanite deposit with substantial lithium potential.

It is the largest known contained borate occurrence in the world not owned by the two major borate producers Rio Tinto (ASX:RIO) and Turkish state-owned Eti Maden.

The JORC Resource at Fort Cady has 13.9 Mt of contained boric acid.

ABR has met a number of major milestones in the last month, including finalisation of site layout and discussions with potential partners with respect to the sale of boric acid and gypsum once in production.

Management also said that positive discussions with regulatory bodies regarding project support and permitting were ongoing.

The company has established a timeline that projects first production in the fourth quarter of 2020, representing a comparatively swift transition from construction to production.

While this is subject to financing and permitting, the following timetable provides a comprehensive outline of the company’s goals and development schedule.

Commenting on these developments, ABR Managing Director Michael Schlumpberger said, “The DFS for our Fort Cady Borate Mine remains on target for completion in Q4 CY2018.

“We have now finalised our site layout that is consistent with our approved Plan of Operations (mining permit).

“We are pleased to be targeting, subject to financing and final permitting, the commencement of production in Q4, CY2020.

“We continue to believe that we have all the right ingredients to become a globally significant producer of borates, including a large colemanite resource that has been successfully mined before, likely low pre-production capex, a brilliant logistics solution and close access to all necessary utilities.”

It is worth noting that this is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.

Product development and partners

Of course, as is the case with any commodity, having a buyer for your product is essential and management had some interesting comments to make on this note.

As mentioned, the company continues to have positive discussions with potential partners for the sale of boric acid and gypsum.

In particular though, management is encouraged by its gypsum discussions and believes there is a large Californian market that can potentially absorb its by-product gypsum at full production.

In addition to discussions with respect to boric acid and gypsum, ABR is considering the option of selling by-product hydrochloric acid (HCl) from its potassium sulphate (SOP) production.

Discussions are progressing with large users of HCl in California that have the potential of underwriting an increase in SOP production.

Whilst discussions are at a preliminary stage, the company is considering options of decoupling the SOP production from the broader project with a view to financing that element of the project via alternate means.

This could potentially have a positive benefit on project financing, an important factor in derisking the development process, and quite often a share price catalyst.

S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.

Conflict of Interest Notice

S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.

Publishers Notice

The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.

Facebook
Twitter
LinkedIn